Community Financial Services Group LLC Purchases 8,387 Shares of Zoetis Inc. (NYSE:ZTS)

Community Financial Services Group LLC boosted its position in Zoetis Inc. (NYSE:ZTS) by 34.8% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 32,481 shares of the company’s stock after acquiring an additional 8,387 shares during the period. Zoetis accounts for 1.3% of Community Financial Services Group LLC’s investment portfolio, making the stock its 25th biggest position. Community Financial Services Group LLC’s holdings in Zoetis were worth $6,346,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of ZTS. Global Assets Advisory LLC purchased a new position in shares of Zoetis during the first quarter valued at about $8,831,000. Franklin Street Advisors Inc. NC grew its holdings in shares of Zoetis by 4.3% during the 1st quarter. Franklin Street Advisors Inc. NC now owns 121,024 shares of the company’s stock worth $20,478,000 after acquiring an additional 5,035 shares during the period. Prevail Innovative Wealth Advisors LLC raised its position in shares of Zoetis by 24.5% in the 1st quarter. Prevail Innovative Wealth Advisors LLC now owns 18,977 shares of the company’s stock worth $3,211,000 after acquiring an additional 3,738 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S lifted its stake in shares of Zoetis by 58.6% in the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 41,931 shares of the company’s stock valued at $7,095,000 after purchasing an additional 15,491 shares during the period. Finally, Duality Advisers LP boosted its position in shares of Zoetis by 43.7% during the first quarter. Duality Advisers LP now owns 40,641 shares of the company’s stock valued at $6,877,000 after purchasing an additional 12,359 shares in the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Zoetis Stock Down 2.0 %

Shares of ZTS stock traded down $3.83 during mid-day trading on Monday, hitting $189.45. The company’s stock had a trading volume of 959,459 shares, compared to its average volume of 2,518,894. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.09 and a current ratio of 3.45. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $201.92. The stock has a market cap of $86.45 billion, a price-to-earnings ratio of 36.53, a PEG ratio of 3.00 and a beta of 0.89. The business has a 50-day moving average price of $188.98 and a 200 day moving average price of $177.17.

Zoetis (NYSE:ZTS) last issued its earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. The business had revenue of $2.36 billion during the quarter, compared to analyst estimates of $2.31 billion. Zoetis had a return on equity of 50.67% and a net margin of 26.29%. During the same quarter in the previous year, the firm earned $1.41 EPS. Zoetis’s revenue was up 8.3% on a year-over-year basis. Research analysts predict that Zoetis Inc. will post 5.83 EPS for the current fiscal year.

Zoetis Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be issued a dividend of $0.432 per share. The ex-dividend date of this dividend is Thursday, October 31st. This represents a $1.73 annualized dividend and a dividend yield of 0.91%. Zoetis’s payout ratio is 33.14%.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Stifel Nicolaus increased their price objective on Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a report on Wednesday, September 18th. JPMorgan Chase & Co. boosted their price objective on shares of Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Piper Sandler upped their price objective on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, August 14th. BTIG Research boosted their price target on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, August 12th. Finally, Argus raised Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Ten research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Zoetis currently has an average rating of “Buy” and a consensus target price of $221.44.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.